Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Hepion Pharmaceuticals, Inc. (HEPA) had Stock-Based Compensation of $0.79M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-1.55M |
|
-- |
|
-- |
|
$1.20M |
|
$-1.20M |
|
$-0.35M |
|
$-1.55M |
|
$-1.55M |
|
$-1.55M |
|
$-1.55M |
|
$-1.55M |
|
$-1.55M |
|
$-1.20M |
|
$-0.41M |
|
0.12M |
|
0.12M |
|
$-9.35 |
|
$-9.35 |
|
| Balance Sheet Financials | |
$1.61M |
|
-- |
|
$0.00M |
|
$1.61M |
|
$3.14M |
|
-- |
|
$0.33M |
|
$3.48M |
|
$-3.56M |
|
$-1.86M |
|
$-1.86M |
|
0.14M |
|
| Cash Flow Statement Financials | |
$-18.22M |
|
$-0.60M |
|
$4.35M |
|
$14.79M |
|
$0.41M |
|
$-14.38M |
|
|
Stock-Based Compensation |
$0.79M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.51 |
|
-- |
|
-- |
|
-- |
|
-1.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.49% |
|
83.05% |
|
-95.89% |
|
83.05% |
|
$-13.41 |
|
$-148.10 |
|
$-148.10 |
|